Found: 4
Select item for more details and to access through your institution.
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 579, p. 1, doi. 10.1126/scitranslmed.abb6282
- By:
- Publication type:
- Article
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27525-9
- By:
- Publication type:
- Article
Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article